Clinical pharmacology of digitalis glycosides.
D000284:Administration, Oral; D000368:Aged; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000494:pharmacology*; D004074:Digitoxin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000652:urine; D004077:Digoxin / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D005243:Feces / Q000032:analysis; D006325:Heart Atria / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007674:Kidney Diseases / Q000150:complications; D008107:Liver Diseases / Q000150:complications; D008286:Malabsorption Syndromes / Q000150:complications; D009765:Obesity / Q000150:complications; D013610:Tachycardia / Q000139:chemically induced; D013959:Thyroid Diseases / Q000150:complications; D014316:Tritium; D014882:Water-Electrolyte Balance
D004071:Digitalis Glycosides; D014316:Tritium; D004077:Digoxin; D004074:Digitoxin